Arthur G. Cook is Principal, ZS Associates.

New technologies are impacting the speed-to-therapy within hub services. In a conversation with Pharmaceutical Executive, ...

Patel explores how automation and AI are accelerating speed-to-therapy within hub services, the strategic implications of ...

The court found ACIP member replacements were executed without required FACA processes, undermining transparency, balanced representation, and public participation in federal vaccine advisory work. A ...

Vera Pomerantseva, Director of Product Management for RBQM, eClinical Solutions, touched on AI's growing role in clinical ...

PE: Can broad LLMs and smaller, focused LLMs coexist? Rusher: I think they’ll coalesce. It’s already happening where there’s very specific versions of certain LLMs for pharmaceutical research. They ...

Jiang Li, CEO of Vivalink, continues his conversation with Pharmaceutical Executive, this time discussing the impact of continuous monitoring on patient adherence. Clinical trials continue to ...

Closed, agency-only AI platforms that cannot integrate into enterprise ecosystems face vendor-lock risk and likely attrition ...

A growing cohort without protective immunity, combined with measles’ high basic transmissibility, enables rapid propagation ...

How are the Rare Disease Evidence Principles (RDEP) reshaping evidentiary expectations? Laksheeta Johari: This is a very ...

CEO of Vivalink, continues his conversation with Pharmaceutical Executive, this time discussing the impact of continuous monitoring on patient adherence.

Jiang Li, CEO of Vivalink, continues his conversation with Pharmaceutical Executive, this time discussing the impact of continuous monitoring on patient adherence. Jeanne Marrazzo, MD, FIDSA, MPH, CEO ...